Transitioning to GLP-1 RAs and SGLT2 Inhibitors As the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes
Current Atherosclerosis Reports（2022）
关键词
Diabetes,Hyperglycemia,Cardiovascular disease,Sodium-glucose co-transporter-2,Glucagon-like peptide 1 receptor agonist
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要